Plewman Patrick's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Feb 20, 2026
- Accession no.
- 0001497368-26-000002
- Filed
- Feb 20, 2026
- Trade date
- Feb 18-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $196.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Plewman PatrickCIK 0001497368 | Officer (SVP for Diagnostic Services) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | AGrant or awardAcquired | +1,952 | $0.00 | $0 | 17,333 | Direct | |
| Feb 18, 2026 | Common Stock | FTax withholdingDisposed | −244 | $210.01 | −$51,242.44 | 17,089 | Direct | |
| Feb 18, 2026 | Common Stock | FTax withholdingDisposed | −293 | $206.99 | −$60,648.07 | 16,796 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −958 | $204.83 | −$196,227.14 | 15,838 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | AGrant or awardAcquired | +9,009 | $0.00 | $0 | 9,009 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.